Variant report
Variant | nsv961673 |
---|---|
Chromosome Location | chr2:77411743-77418339 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs192861133 | chr2:77412202-77412203 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs541460601 | chr2:77412236-77412237 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs183804753 | chr2:77412239-77412240 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs576313122 | chr2:77412251-77412252 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs188442183 | chr2:77412255-77412256 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs565160720 | chr2:77412262-77412263 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs369143759 | chr2:77412265-77412266 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs548696346 | chr2:77412275-77412276 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs7558042 | chr2:77412302-77412303 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs559587564 | chr2:77412307-77412308 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs7572144 | chr2:77412369-77412370 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs530136225 | chr2:77412383-77412384 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs548586990 | chr2:77412482-77412483 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs527731132 | chr2:77412486-77412487 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs150028480 | chr2:77412494-77412495 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs552451377 | chr2:77412509-77412510 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs17013771 | chr2:77412514-77412515 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs534511468 | chr2:77412518-77412519 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs546723124 | chr2:77412553-77412554 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs568044335 | chr2:77412564-77412565 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs535114259 | chr2:77412575-77412576 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs556554628 | chr2:77412581-77412582 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs76167775 | chr2:77412625-77412626 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs537352281 | chr2:77412721-77412722 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs558975889 | chr2:77412724-77412725 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs538150359 | chr2:77412752-77412753 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs577412167 | chr2:77412811-77412812 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs72913923 | chr2:77412829-77412830 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs17013773 | chr2:77412859-77412860 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs574849395 | chr2:77412862-77412863 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs193227388 | chr2:77412882-77412883 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs575572405 | chr2:77412934-77412935 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs568351223 | chr2:77412935-77412936 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs576728357 | chr2:77412982-77412983 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs145324177 | chr2:77413001-77413002 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs552547065 | chr2:77413015-77413016 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs10176578 | chr2:77413035-77413036 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs76225286 | chr2:77413042-77413043 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs184729905 | chr2:77413068-77413069 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs10191311 | chr2:77413071-77413072 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
41 | rs535196379 | chr2:77413102-77413103 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs188002956 | chr2:77413108-77413109 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs113362510 | chr2:77413149-77413150 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs539042134 | chr2:77413194-77413195 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs559229703 | chr2:77413195-77413196 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs577451094 | chr2:77413249-77413250 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs34572218 | chr2:77413297-77413298 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs572743309 | chr2:77413321-77413322 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs191456363 | chr2:77413347-77413348 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs575036632 | chr2:77413349-77413350 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Chronic lymphocytic leukemia | 21546498 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Adrenal tumor | 17535989 | CNVD |
Breast cancer | 21264507 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Medulloblastoma | 17522785 | CNVD |
Cancer | 23418310 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
Prostate cancer | 18632612 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Autism | 17483303 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Lung cancer | 18438408 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Mental retardation | 17124404 | CNVD |
Basal cell lymphoma | 19029149 | CNVD |
Diffuse large b-cell lymphoma | 19029149 | CNVD |
Cancer | 17440070 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Attention deficit hyperactivity disorder | 21324949 | CNVD |
Breast cancer | 16272173 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Breast cancer | 22522925 | CNVD |
Epilepsy | 22083797 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:77412200-77413000 | Enhancers | HepG2 | liver |
2 | chr2:77413000-77415200 | Weak transcription | HepG2 | liver |
3 | chr2:77415200-77415800 | Enhancers | HepG2 | liver |
4 | chr2:77415800-77417600 | Weak transcription | HepG2 | liver |
5 | chr2:77417600-77418000 | Enhancers | HepG2 | liver |
6 | chr2:77417800-77419200 | Enhancers | Liver | Liver |
7 | chr2:77418000-77418600 | Flanking Active TSS | HepG2 | liver |